Taiwan FDA registration c3f4c34ac193e6d81c1c88146ba15685

The Binding Site Optilite C3c Kit

TW: 邦迪斯歐普羅補體C3c分析套組

Taiwan·Risk Class 2·MD·THE BINDING SITE GROUP LTD·Registered Feb 26, 2019 – Feb 26, 2024Expired

Registration details

Analysis ID: c3f4c34ac193e6d81c1c88146ba15685
License Form: Ministry of Health Medical Device Import No. 032192
Customs Code: DHA05603219203

Company information

Manufacturer: THE BINDING SITE GROUP LTD
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This product is used with the Binding Site Plite analyzer for the quantitative determination of complement C3c in vitro, and is suitable for plasma of serum, lithium heparin salt or EDTA anticoagulant.
Product Type (Level 1): C Immunology and microbiology devices
Product Type (Level 2): C5240 Complement Component Immunoassay System
Import Information: Imported from abroad

Dates and status

Registration Date: Feb 26, 2019
Expiry Date: Feb 26, 2024

About this record

Access comprehensive regulatory information for The Binding Site Optilite C3c Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c3f4c34ac193e6d81c1c88146ba15685 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.